top of page
  • Writer's pictureCheckers

Can B Corp: A Billion-Dollar Opportunity in the CBD Industry

The CBD industry is one of the fastest-growing sectors in the world, with a projected compound annual growth rate of 21.2% from 2021 to 2028, reaching a market size of $13.4 billion by 2028. The increasing demand for CBD products, driven by their therapeutic benefits and consumer preferences, has created a lucrative opportunity for companies that can deliver high-quality, innovative, and compliant solutions.



Can B Corp (OTCQB: CANB), a US-based Health and Wellness company, is capitalizing on the expanding opportunities presented by the booming CBD market. The most recent update for CANB, an 8k released yesterday, disclosed the company has just completed the acquisition of several innovative patents through its subsidiary, Nascent Pharma, LLC. These patents cover liquid formulations of cannabis, including beverages, tinctures, vape pen liquids, and liquid-filled capsules. These formulations have patented uses for managing numerous debilitating conditions, such as cancer, irritable bowel syndrome, chronic pain, post-traumatic stress disorder, anxiety, sleep disorders, and opioid dependencies. Through Nascent, the company plans to pursue opportunities to license and develop uses for the patents.


These patents are not only groundbreaking for their scientific and medical potential, but also for their economic value. An independent valuation firm valued the patents at $122 million after applying a 90% discount. However, without this extremely conservative discount, the patents are valued at over 1 billion dollars, highlighting the immense opportunity they hold for CANB. Owning a billion-dollar patent portfolio gives Can B Corp a unique advantage over its competitors and a significant edge in the CBD market.


From a financial perspective, CANB has demonstrated strategic foresight and financial performance, making significant advancements in its operational efficiency and revenue growth. The company recently relocated its headquarters and warehouse to a more cost-effective location, resulting in annual savings of nearly $500,000. In 2023 the company reported a record revenue of $6.7 million – a record-high and a 45% increase from the previous year. The company has also secured valuable biomass agreements and optimized its corporate debt, strengthening its balance sheet and cash flow.



For current shareholders, CANB is doing everything right: providing a rare and valuable opportunity to be part of a company that is a leader in their industry. The foundation of the company is strong, supported by its unwavering commitment to quality, innovation, and market leadership. This dedication is vividly showcased by the significant valuation of its patent portfolio alongside sustained revenue growth, illustrating a commitment to enhancing shareholder value in the fast-evolving CBD sector.


Additionally, CANB's strategic share structure, with 40,703,501 outstanding shares, of which half are restricted, underscores the potential for market stability and growth. This strategic approach to share management aligns with the company's upward trajectory and underscores its commitment to shareholder value. The stock price of CANB was above $1 just a year ago, illustrating a significant benchmark in the company's financial journey. Current developments suggest that reaching these levels again would mark the beginning of a new chapter for CANB, potentially paving the way for even greater accomplishments, including the possibility of a Nasdaq listing. This perspective fosters a positive view for existing shareholders of CANB and highlights the company's solid stance within the dynamic CBD market.


Can B Corp stands out in the CBD industry with its high-quality products, operational efficiency, revenue growth. The company has a unique advantage over its competitors and now owns the rights to patents valued over a billion dollars, which have the potential to revolutionize the CBD market and address various health challenges. The company also has a favorable share structure, which boosts the chances of uplisting to a major exchange down the road without requiring much, if any, restructuring. As the CBD sector continues to grow and evolve, Can B Corp is well-positioned to capitalize on the emerging opportunities and challenges.


Mt. Zion Market Ventures has received compensation for the creation and dissemination of this article. For more information, please visit https://www.opendisclose.com/


35 views0 comments

Comments


bottom of page